News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Centering the Unique Needs and Experiences of Cancer Patients No Matter the Political Environment – BrightEdge – ACS
Lisa Lacasse/smartbrief.com
Nov 26, 2024, 16:59

Centering the Unique Needs and Experiences of Cancer Patients No Matter the Political Environment – BrightEdge – ACS

BrightEdge – American Cancer Society shared a post on LinkedIn:

“President of our nonpartisan advocacy affiliate American Cancer Society Cancer Action Network (ACS CAN), Lisa A. Lacasse reminded Summit attendees why we must center the unique needs and experiences of cancer patients no matter the political environment.

At American Cancer Society, we believe that amplifying patient voices is essential for driving impactful change in cancer research and treatment.”

Patients

For more updates, follow OncoDaily.

ACS CAN American Cancer Society BrightEdge - American Cancer Society cancer Cancer research cancer treatment Lisa A. Lacasse OncoDaily Oncology patients political environment Research summit
Special Coverage
Science
Jan 6, 2025, 13:02
Max Julvé: Toxicity management strategies for solid tumour cell therapy
Science
Jan 6, 2025, 12:59
Arndt Vogel: The use of immunotherapy pre-liver transplant
Science
Jan 6, 2025, 12:40
Chaitanya Bandlamudi: Detailed clinico-genomic landscape of pancreatic adenocarcinomas
Science
Jan 6, 2025, 12:37
Sharlene Gill: Adjuvant immunotherapy in patients with resected ESO/GEJ cancer
Career
Jan 6, 2025, 12:35
Kicking of exciting new season of Inside Cancer Careers with LeeAnn Bailey - Train at NCI
Blog
Jan 6, 2025, 12:33
Revolutionizing Cancer Care - Canary Oncoceutics
Blog
Jan 6, 2025, 12:31
Banu Arun: Pioneering New Horizons in BRCA-Positive Breast Cancer Treatment
Blog
Jan 6, 2025, 12:31
Raising Radon Awareness - ALCSI
Insight
Jan 6, 2025, 12:28
We are proud to be the first non-profit 100% dedicated to Myelodysplastic Syndromes - MDS Foundation
Insight
Jan 6, 2025, 12:15
Erman Akkus: Adjuvant pembrolizumab after surgery in high risk muscle invasive bladder cancer
Blog
Jan 6, 2025, 11:56
Julie Gerberding: Extermely fortunate to benefit from Ellen Sigal’s passionate leadership as a member of FNIH Board
Blog
Jan 6, 2025, 11:54
Pashtoon Kasi: Have to be mindful of rare side effects of Immunotherapy